Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECT with or without sodium valproate in bipolar mania
IRCT201608049014N108Phase 2Completed
- Sponsor
- Zahedan University of Medical Sciences
- Start
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of valproic acid in bipolar disorder (BD) (2 arms), sponsored by Zahedan University of Medical Sciences. Primary endpoints: Cognitive impairments and Treatment response. Started Aug 2016; status: completed.
02
Drugs
valproic acid
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on IRCT201608049014N108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201608049014N108.